Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1986
08/13/1986EP0190946A2 Novel cyclic hexapeptide LHRH antagonists
08/13/1986EP0190736A2 Chemical derivatives of GHL-Cu
08/13/1986EP0190686A2 Method of producing interferon-gamma
08/13/1986EP0190652A1 Genes for biologically active proteins
08/13/1986EP0190606A2 Sorbent for the purification of proteins
08/13/1986EP0190597A2 Retro-inverso analogs of the bradykinin potentiating peptide bpp 5a
08/13/1986EP0190464A2 Novel anti-cancer drugs
08/13/1986EP0190337A1 A process for proliferation of wholly or partially differentiated beta-cellls
08/13/1986EP0190299A1 NEW p-PHENYLENEDIAMINE PEPTIDES AND REACTANCE CONTAINING THEM FOR THE DETERMINATION OF PROTEASES OF THE BLOOD COAGULATION SYSTEM
08/13/1986EP0190254A1 Cloned gene and method for making and using the same
08/13/1986EP0190244A1 Cell treatment
08/13/1986EP0190224A1 PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA [b] PYRROLE-2-CARBOXYLATE
08/13/1986EP0190205A1 Method for determining mimotopes.
08/13/1986EP0190185A1 Monoclonal antibodies and their use
08/13/1986EP0190163A1 Growth-related hormone
08/12/1986US4605643 Ovine GRF
08/12/1986US4605642 Corticotropin releasing factor; antisecretory agents
08/12/1986US4605641 Synthetic vasoactive intestinal peptide analogs
08/12/1986US4605515 Calcitonin-(1-23)-peptide amide
08/12/1986US4605514 Des-4-leucine-calcitonin
08/12/1986US4605512 Veterinary medicine
08/12/1986CA1209502A1 Products displaying the antigenicity of hepatitis b virus e antigens and methods of producing those antigens
08/12/1986CA1209501A1 Expression vector
08/12/1986CA1209473A1 Stable interferon b-composition and a method of stabilizing interferon b
08/06/1986EP0190099A2 Polypeptide factors from colostrum
08/06/1986EP0190049A2 Method for selecting hybridomas producing antibodies specific to inaccessible cell surface antigens
08/06/1986EP0190033A2 Monoclonal antibody against a ras oncogene P21 related dodecapeptide
08/06/1986EP0190018A2 Use of transforming growth factor to promote wound healing and composition therefor
08/06/1986EP0189998A1 A process for preparing glucagon or derivatives thereof in a transformed yeast strain
08/06/1986EP0189958A2 Canine parvovirus vaccines
08/06/1986EP0189784A1 Human natural inhibitor of collagenases
08/06/1986EP0189688A2 Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
08/06/1986EP0189628A1 Detection of B-Cell Neoplasms
08/06/1986EP0189481A1 Insulin-like Growth factor II.
08/06/1986EP0189463A1 Yeast cloning vehicle
08/06/1986EP0189451A1 Monoclonal antibodies and their use
08/06/1986EP0189450A1 Monoclonal antibodies and their use
08/06/1986EP0189431A1 Process for purifying a protein.
08/05/1986US4604402 Hypotensive agnets
08/05/1986US4604378 Basic V1 -vasopressin antagonists
08/05/1986US4604377 Stable; regenerated in aqueous veldicle for human injection; trating adis
08/05/1986US4604376 Enteric compounds and complexes
08/05/1986US4604359 Microbial expression of a gene for human growth hormone
08/05/1986US4604284 Homogeneous immune interferon fragment
08/05/1986US4604238 Analogs of calcitonin
08/05/1986US4604237 Des-21-threonine-calcitonin
08/05/1986US4604236 Calcitonin analogs
08/05/1986US4604235 Purification of monoclonal antibodies
08/05/1986US4604234 Wound healing agents, dna promoter
08/05/1986CA1209127A1 Protein derivative with remnants absorbing the uv rays attached to it, preparation process and compositions containing said derivative
08/05/1986CA1209038A1 Crystalline human leukocyte interferon
07/1986
07/31/1986WO1986004422A1 Test for campylobacter
07/31/1986WO1986004420A1 Antibody preparation with specificity for aliphatically bound 4-(2-aminoethyl)imidazolyl group, manufacture and use of the antibody preparation
07/31/1986WO1986004356A1 AraB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES
07/31/1986WO1986004352A1 Immunoassay systems for the detection of salmonella
07/31/1986WO1986004336A1 Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses
07/31/1986WO1986004335A1 Process for the preparation of insulin precursors contained in reaction mixtures resulting from the preparation of insulin precurssors by plaiting respective s-sulphonates
07/31/1986WO1986004334A1 Immunoregulatory peptides
07/31/1986WO1986004240A1 Plasma substitute
07/31/1986WO1986004239A1 Brain derivable polypeptide factors and antibodies
07/31/1986WO1986004217A2 Protein hydrolysates, production process and drugs containing th em
07/31/1986WO1986003495A3 Derivatives of substances p and of fragments thereof
07/30/1986EP0189326A2 Derivatives of arginine vasopressin antagonists
07/30/1986EP0189305A2 Peptide derivatives
07/30/1986EP0189084A2 Use of a peptide having cardiac anti-hypertrophic activity
07/30/1986EP0188920A2 Interleukin 1 and its derivative
07/30/1986EP0188864A1 DNA encoding human interleukin 1 alpha and the amino acid chain corresponding thereto and vectors and hosts containing such DNA; and the preparatiion thereof
07/30/1986EP0188574A1 Retroviral vaccines and vectors and methods for their construction
07/30/1986EP0188555A1 Yeast cloning vehicle
07/30/1986EP0188491A1 Monoclonal antibodies and their use
07/29/1986US4603120 Antidizbetic, hemosatatic, somatostatin analogs
07/29/1986US4603112 Modified vaccinia virus
07/29/1986US4603106 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
07/29/1986US4603010 Lipoprotein fractionation
07/29/1986CA1208583A1 Process for producing t cell-activating factor
07/29/1986CA1208577A1 Test for salmonella in food
07/29/1986CA1208576A1 Monoclonal antibodies specific to cea, a process for producing such antibodies and the use of such antibodies
07/29/1986CA1208546A1 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
07/23/1986EP0188400A2 Oligopeptides, intermediates and process for their preparation
07/23/1986EP0188312A2 Process for the production of a protein
07/23/1986EP0188262A2 Process for the isolation of chicken egg white cystatine, antiviral agents containing it and its use as viral protease inhibitor
07/23/1986EP0188256A2 Metal radionuclide labeled proteins for diagnosis and therapy
07/23/1986EP0188214A2 Novel growth hormone-releasing peptides and method of treating mammals therewith
07/23/1986EP0188004A2 Refinement of raw proteines
07/23/1986EP0187991A2 Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism
07/23/1986EP0187894A1 A size selective catalyst comprising a fibrin gel
07/23/1986EP0187814A1 Diagnostic assay for inhibitor or tissue-type and urokinase-type plasminogen activators.
07/23/1986EP0187802A1 Monoclonal antibodies and their use
07/23/1986EP0187801A1 Monoclonal antibodies and their use
07/22/1986US4601980 Microbial expression of a gene for human growth hormone
07/22/1986US4601979 Process for preparing human insulin or B-30 esters thereof
07/22/1986US4601852 Process for the preparation of human or the derivatives thereof from pig insulin or the derivatives thereof
07/22/1986CA1208130A1 Ultrapurification of factor viii
07/17/1986WO1986004144A1 Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
07/17/1986WO1986004094A1 Dna sequences, recombinant dna molecules and processes for producing human lipocortin-like polypeptides
07/17/1986WO1986004093A1 Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
07/17/1986WO1986004090A1 Methods and compositions for the detection of familial hypercholesterolemia
07/17/1986WO1986004069A1 Human endogenous cancer regulatory factors
07/17/1986WO1986004068A1 Homogeneous erythropoietin
07/17/1986WO1986004067A1 Method for purifying an interferon